AstraZeneca PLC (NASDAQ:AZN)

60.20
Delayed Data
As of Jan 20
 +0.69 / +1.16%
Today’s Change
46.48
Today|||52-Week Range
64.21
+3.35%
Year-to-Date
Is Ocugen Stock a Buy Now?
Jan 20 / MotleyFool.com - Paid Partner Content
Here's Some Good News for Novavax That Investors Are Overlooking
Jan 18 / MotleyFool.com - Paid Partner Content
Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant
Jan 20 / Zacks.com - Paid Partner Content
This Could Be Another Blockbuster Indication for AstraZeneca
Jan 17 / MotleyFool.com - Paid Partner Content
3 Under-the-Radar COVID Stocks
Jan 19 / MotleyFool.com - Paid Partner Content
2 Risky Growth Stocks That Could Make You Filthy Rich
Jan 16 / MotleyFool.com - Paid Partner Content
Will Moderna (MRNA) Continue to Ride on Vaccine Sales in 2022?
Jan 18 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) COVID-19 Booster Dose Useful Against Omicron
Jan 14 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Enhertu sBLA Receives FDA Priority Tag
Jan 18 / Zacks.com - Paid Partner Content
1 Top Dividend Stock to Buy and Hold in 2022 and Beyond
Jan 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close59.48
Today’s open60.20
Day’s range59.84 - 60.62
Volume6,171,965
Average volume (3 months)5,048,068
Market cap$182.4B
Data as of 4:00pm ET, 01/20/2022

Growth & Valuation

Earnings growth (last year)+137.38%
Earnings growth (this year)+29.50%
Earnings growth (next 5 years)+19.67%
Revenue growth (last year)+13.16%
P/E ratio108.5
Price/Sales4.76
Price/Book9.89

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.09-0.10%
MRKMerck-0.22-0.27%
NVONovo Nordisk-0.05-0.05%
BMYBristol-Myers Squibb-0.15-0.23%
Data as of 5:08pm ET, 01/20/2022

Financials

Next reporting dateFebruary 10, 2022
EPS forecast (this quarter)$0.77
Annual revenue (last year)$27.6B
Annual profit (last year)$3.2B
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts